Quotient Investors’s Meridian Bioscience Inc VIVO Stock Holding History

Quotient Investors’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-25,200	Closed	-$486K	–	198
2016 Q3	$486K	Sell	25,200 -3,200	-11%	-$62.6K	0.31%	112
2016 Q2	$554K	Hold	28,400	–	–	0.26%	114
2016 Q1	$585K	Sell	28,400 -2,500	-8%	-$49.3K	0.21%	123
2015 Q4	$634K	Buy	30,900 +10,900	+55%	+$209K	0.24%	107
2015 Q3	$342K	Hold	20,000	–	–	0.08%	146
2015 Q2	$373K	Buy	+20,000	New	+$371K	0.05%	187

Other funds holding VIVO

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Quotient Investors's VIVO Position: Q4 2016 in Review

Quotient Investors sold out of Meridian Bioscience Inc (VIVO) in Q4 2016, closing a stake of 25,200 shares — an estimated $486K sold.

Quotient Investors first reported a position in VIVO in Q2 2015 and held it in 6 quarters. The position peaked at $634K in Q4 2015. 180 funds tracked by Wall St. Rank hold VIVO as of Q4 2016.

Quotient Investors reported no remaining Meridian Bioscience Inc position as of Q4 2016 after selling out during the quarter.
Quotient Investors sold 25,200 Meridian Bioscience Inc shares in Q4 2016, an estimated $486K.
Quotient Investors first reported a position in Meridian Bioscience Inc in Q2 2015 and held it in 6 quarters.
Quotient Investors's Meridian Bioscience Inc position peaked at $634K in Q4 2015.
180 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q4 2016.

Based on Quotient Investors's 13F filing for Q4 2016, filed 25 Jan 2017.